Description: The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the performance of the S&P Pharmaceuticals Select Industry Index. The Index represents the pharmaceuticals sub-industry portion of the S&P Total Stock Market Index. The Index is one of nineteen (19) of the S&P Select Industry Indexes, each designed to measure the performance of a narrow sub-industry determined based on the Global Industry Classification Standards. Membership in the Select Industry Indexes is based on the GICS classification, as well as liquidity and market cap requirements. Companies in the Select Industry Indexes are classified based primarily on revenues; however, earnings and market perception are also considered. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.
|BMY||Bristol-Myers Squibb Company||4.35%|
|ABBV||Abbvie Inc. Common Stock||3.9%|
|JNJ||Johnson & Johnson||3.78%|
Data is provided by Zacks Investment Research